UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Mundipharma to market Biosolution's knee cartilage defect treatment
Biosolution said that it has signed an exclusive sales agreement with Mundi...
by Lee Han-soo
|
2020-01-07 16:11
라인
Fenbendazole craze expands to human parasiticide
Following the craze over fenbendazole, a dog deworming drug, in treating ca...
by Lee Han-soo
|
2020-01-07 12:33
라인
Eliquis price cut delayed amid prolonged administrative suit
The Ministry of Health and Welfare’s order in June to cut the price of BMS ...
by Kim Yun-mi
|
2020-01-07 11:32
라인
Chinese drugmaker Mebo establishes branch in Korea
Mebo Group, a Chinese firm specializing in regenerative medicine, has estab...
by Lee Han-soo
|
2020-01-06 14:40
라인
[New Year Special] Boryung, Hanmi in fierce battle to fill ranitidine void
After the regulator kicked ranitidine and nizatidine out of the market due ...
by Jeong Sae-im
|
2020-01-03 17:56
라인
Bukwang, Sanofi Aventis Korea to co-promote hypertension med
Bukwang Pharmaceutical said that it would promote and market Aprovel and Co...
by Lee Han-soo
|
2020-01-03 17:55
라인
Daewoong launches oral typhoid fever vaccine
Daewoong Pharmaceutical said that it has launched Vivotif, an oral typhoid ...
by Lee Han-soo
|
2020-01-03 17:55
라인
[New Year Special] Rise of digital therapeutics to change healthcare scene for good
If a person gets sick, he or she visits a doctor, gets a prescription, take...
by Lee Han-soo
|
2020-01-03 14:57
라인
SK Bioscience’s influenza vaccine nabs WHO certification
SK Bioscience said that the World Health Organization (WHO) has granted pre...
by Lee Han-soo
|
2020-01-03 14:14
라인
Daewoong to kick off P3 trial of Nabota in China
Daewoong Pharmaceutical said Tuesday that it held a meeting with Chinese re...
by Lee Han-soo
|
2020-01-02 17:36
라인
FDA OKs Huons' generic of topic anesthetic injection
Huons said that the U.S. Food and Drug Administration has approved the comp...
by Lee Han-soo
|
2020-01-02 14:30
라인
Medytox launches liquid-type BTX 'Innotox 100 unit' in local market
Medytox said that the Ministry of Food and Drug Safety has approved to sell...
by Lee Han-soo
|
2020-01-02 12:12
라인
Korean biopharmaceuticals competitively move abroad to expand global presence
Local pharmaceutical companies are actively advancing to overseas markets. ...
by Jeong Sae-im
|
2019-12-30 17:20
라인
Migraine drug market heats up with Ubrelvy’s arrival
After Lilly’s acute migraine drug Reyvow (ingredient: lasmiditan) obtained ...
by Kim Yun-mi
|
2019-12-27 11:57
라인
Local biopharmaceutical companies suffer from unsatisfactory P3 global trial results
Many of the local biopharmaceutical companies that attracted high expectati...
by Jeong Sae-im
|
2019-12-27 07:06
라인
Dupixent to get coverage from January
Sanofi’s new biologic agent Dupixent (ingredient: dupilumab) for severe ato...
by Kim Yun-mi
|
2019-12-24 15:40
라인
‘Korea still slow to expand benefit for new drugs’
Avi Ben-Shoshan, chairman of the Korea Research-based Pharma Industry Assoc...
by Kim Yun-mi
|
2019-12-24 15:37
라인
Shanghai Ocumension to market Huonland's HA eyedrop
Huonland, a joint venture between Huons and Beijing Northland, said that it...
by Lee Han-soo
|
2019-12-23 15:43
라인
Alteogen's growth hormone deficiency treatment wins orphan drug status
Alteogen said that the U.S. Food and Drug Administration has granted an orp...
by Lee Han-soo
|
2019-12-23 14:46
라인
Daewoong partners with Aeon Biopharma to tap therapeutic BTX market
Daewoong Pharmaceutical said that it has agreed with Aeon Biopharma to expa...
by Lee Han-soo
|
2019-12-23 11:23
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top